Kyle Jenne Insider Profile
4 Followers
Kyle Jenne, CCO at Akcea Therapeutics, holds 23.71K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 0.00 shares in Akcea Therapeutics (Ticker: AKCA).
Kyle Jenne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chf GL Pdt Str Ofcr
Roles that Kyle Jenne holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kyle Jenne
Kyle Jenne's Trading History
Akcea Therapeutics
Oct 13, 2020
―
Uninformative Sell
944.02K
$0.00
Ionis Pharmaceuticals
Apr 17, 2026
EVP, Chf GL Pdt Str Ofcr
Uninformative Buy
562.63K
$1.80M
List of latest transactions for each holding click on a transaction to see Kyle Jenne's performance on stock
You May Also Like
Kyle Jenne insider profile FAQ
What is the percentage of profitable transactions made by Kyle Jenne?
The percentage of profitable transactions made by Kyle Jenne is ―.
What is the average return per transaction made by Kyle Jenne?
The average return per transaction made by Kyle Jenne is ―.
What stocks does Kyle Jenne hold?
Kyle Jenne holds: AKCA, IONS stocks.
What was Kyle Jenne’s latest transaction?
Kyle Jenne latest transaction was an Uninformative Buy of $562.63K.
What was Kyle Jenne's most profitable transaction?
Kyle Jenne’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kyle Jenne's role in Akcea Therapeutics?
Kyle Jenne's role in Akcea Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.